tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Cardiomyopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lishmanov, IuB; Maslov, LN; Naryzhnaia, NV | 1 |
Lishmanov, IuB; Maslov, LN; Naryzhnaia, NV; Revinskaia, IuG | 1 |
2 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Cardiomyopathies
Article | Year |
---|---|
[Cardioprotective effects of stimulation of peripheral mu-opiate receptors, and the role of opiatergic mechanisms in the pathogenesis of stress-induced heart damage].
Topics: Animals; Cardiomyopathies; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Immobilization; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Wistar; Receptors, Opioid, mu; Stress, Physiological | 1997 |
[The role of peripheral and central mu-opiate receptors in the modulation of adrenergic cardiac lesions during stress].
Topics: Adrenal Glands; Adrenergic Agents; Animals; Brain; Cardiomyopathies; Catecholamines; Diphosphates; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Guanethidine; Injections, Intraventricular; Male; Myocardium; Oligopeptides; Rats; Rats, Wistar; Receptors, Opioid, mu; Stress, Physiological; Sympathetic Nervous System | 1998 |